` 133750 (MegaMD Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

M
133750
vs
K
KOSPI 200

Over the past 12 months, MegaMD Co Ltd has underperformed KOSPI 200, delivering a return of -30% compared to KOSPI 200's +119% growth.

Stocks Performance
133750 vs KOSPI 200

Loading...
133750
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
133750 vs KOSPI 200

Loading...
133750
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
133750 vs KOSPI 200

Loading...
133750
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
MegaMD Co Ltd vs Peers

KOSPI 200
133750
ADH
SDO
PSON
EDU
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

MegaMD Co Ltd
Glance View

MegaMD Co Ltd sells medical devices and related consumables used mainly in hospitals, clinics, and other healthcare settings. Its business is built around equipment and products that doctors use in treatment rooms and procedures, rather than consumer health products sold in stores. The company makes money by selling these devices and supplies to medical customers, either through direct sales or through distributors. In this kind of business, the first sale of the equipment is often followed by repeat orders for replacement parts and disposable items, which helps tie the company to day-to-day clinical use. What makes MegaMD’s role different is that it sits in the middle of the healthcare value chain: it turns medical engineering into tools that providers can actually use in practice. That means its success depends less on broad consumer branding and more on product reliability, clinical usefulness, and long-term relationships with healthcare buyers.

Intrinsic Value
₩1 169.91
Overvaluation 14%
Intrinsic Value
Price ₩1 366
M
Back to Top